SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Summit Therapeutics Q3'26 Earnings Preview

Summit Therapeutics is scheduled to report Q3'26 results on November 11. Revenue and EPS estimates were provided, but their amounts are omitted here.

SMMT

SMMT (Summit Therapeutics Inc.) is set to announce its Q3'26 results on November 11, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 111.11 thousand USD with EPS (earnings per share) anticipated at (0.28) USD. Learn more deta…

Related stories